<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian journal of Pediatric Hematology and Oncology</title>
<title_fa>Iranian journal of Pediatric Hematology and Oncology</title_fa>
<short_title>Iran J Ped Hematol Oncol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijpho.ssu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-8892</journal_id_issn>
<journal_id_issn_online>2228-6993</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>7</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1394</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2016</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>6</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Association Between RFC1 G80A Polymorphism and Acute Lymphoblastic Leukemia: a Review and Meta-Analysis of 10 Studies</title>
	<subject_fa>قلب</subject_fa>
	<subject>Heart</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background&lt;br&gt;
Evidence indicates RFC1 G80A&amp;nbsp;polymorphism as a risk factor for a&amp;nbsp;number of cancers. Increasing studies have&amp;nbsp;been conducted on the association of&amp;nbsp;RFC1 G80A polymorphism with acute&amp;nbsp;lymphoblastic leukemia (ALL) risk.&amp;nbsp;However, the results were &amp;nbsp;controversial.&amp;nbsp;The aim of the present study was to derive&amp;nbsp;a more precise estimation of the&amp;nbsp;relationship.&amp;nbsp;&lt;/p&gt;

&lt;p&gt;Materials and Method&lt;br&gt;
PubMed, Embase, Web of Science,&amp;nbsp;Cochrane database, and Google Scholar&amp;nbsp;were searched to get the genetic&amp;nbsp;association studies between RFC1 G80A&amp;nbsp;polymorphism and ALL. All eligible&amp;nbsp;studies for the period up to February 2016&amp;nbsp;were identified. Subgroup analyses&amp;nbsp;regarding ethnicity were also&amp;nbsp;implemented. All statistical analyses were&amp;nbsp;done with CMA 2.0.&lt;br&gt;
Results&lt;br&gt;
A total of ten studies comprising of 2,168&amp;nbsp;ALL cases and 2,693 healthy controls&amp;nbsp;were included in this meta-analysis.&amp;nbsp;Overall, no significant association was&amp;nbsp;detected for allelic model (OR = 1.029, 95&amp;nbsp;% CI 0.754- 1.405, P=0.000), Dominant&amp;nbsp;model (OR = 1.619, 95 % CI 0.847-3.094,&amp;nbsp;P=0.145), recessive model (OR = 1.169,&amp;nbsp;95 % CI 10.764-1.790, P=0.429), and&amp;nbsp;homozygote model (OR = 1.288, 95 % CI&amp;nbsp;0.928-1.788, P=0.130). However, there&amp;nbsp;was an obvious association under the&amp;nbsp;heterozygote model (OR = 1.368, 95 % CI&amp;nbsp;1.056- 1.772, P=0.018). Also, in the&amp;nbsp;stratified analysis by ethnicity, no&amp;nbsp;significant association of this&amp;nbsp;polymorphism with risk of OC was found&amp;nbsp;in the Asian and Caucasian populations.&amp;nbsp;However, there was not significant&lt;br&gt;
heterogeneity between heterozygote&amp;nbsp;genetic model (P = 0.15, I2 = 33%) in&amp;nbsp;Caucasian. Therefore, we utilized the&amp;nbsp;fixed-effect model to merge OR value.&lt;br&gt;
Conclusion&lt;br&gt;
Based on the available evidence, no&amp;nbsp;association between RFC1 G80A&amp;nbsp;Polymorphism and ALL risk was&amp;nbsp;observed, even in the subanalysis by&amp;nbsp;ethnicity. The direction of further research&amp;nbsp;should focus not only on the simple&amp;nbsp;relationship of RFC1 G80A Polymorphism&amp;nbsp;and ALL risk, but also on gene&amp;ndash;gene and&amp;nbsp;gene-environment interaction.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Acute lymphoblastic leukemia, Genetic polymorphism, G80A Polymorphism, Meta-analysis, RFC1.</keyword>
	<start_page>52</start_page>
	<end_page>63</end_page>
	<web_url>http://ijpho.ssu.ac.ir/browse.php?a_code=A-10-70-76&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>M</first_name>
	<middle_name></middle_name>
	<last_name>Forat-Yazdi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>F</first_name>
	<middle_name></middle_name>
	<last_name>Hosseini-Biouki</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>J</first_name>
	<middle_name></middle_name>
	<last_name>Salehi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>H</first_name>
	<middle_name></middle_name>
	<last_name>Neamatzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>R</first_name>
	<middle_name></middle_name>
	<last_name>Masoumi Dehshiri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Z</first_name>
	<middle_name></middle_name>
	<last_name>Sadri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>F</first_name>
	<middle_name></middle_name>
	<last_name>Ghanizadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>R</first_name>
	<middle_name></middle_name>
	<last_name>Sheikhpour</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>H</first_name>
	<middle_name></middle_name>
	<last_name>Zare-Zardini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
